Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00095082
Status:
COMPLETED
Last Update Posted:
2017-01-27
First Post:
2004-10-29
Brief Title:
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
NN304-1430
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novo Nordisk AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None